Stamos Capital Partners
Stamos Capital Partners, L.P. is an independent, privately owned investment management firm with more than $4 billion in assets under management.* Our primary mission is to serve high-net-worth individuals, family offices, private foundations, endowments, trusts, and other clients that share our firm’s core values. We seek to preserve and build wealth for our clients and investors through an endowment-style approach that utilizes a diversified, global asset allocation intended to achieve attractive, long-term returns.
Aenitis Technologies is a French start-up founded in July 2014 by Mauricio Hoyos and Jean-Luc Aider, both researchers associated with the CNRS at the PMMH Laboratory in Paris. The company specializes in the development of medical devices aimed at enhancing cell therapy preparations. By utilizing acoustophoresis technologies, Aenitis Technologies creates innovative solutions for the separation, manipulation, and filtration of biological elements. Their focus is on addressing challenges faced by cell therapy units and blood banks, particularly in areas such as cell sorting, washing, and isolation. Aenitis Technologies aspires to lead the market in filtering and separating solutions through their advanced acoustic preparation techniques, with the ultimate goal of revolutionizing practices in public health.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.